Farnesoid X receptor (FXR), a nuclear receptor that primarily regulates bile acid metabolism and plays a key role in lipid and glucose metabolism, is essential in the pathophysiology of MASLD-related liver cancer. The gene discussed is NR1H4; the disease is metabolic dysfunction-associated steatotic liver disease.